Michael Weinstein
Recent Quotes
"Over the next couple of years we expect revenue and EPS growth to reaccelerate for JNJ."
—
Michael Weinstein, J.P. Morgan
(1/15/13)
more >
"In Q2/12, MDT's revenue growth accelerated to a three-year high."
—
Michael Weinstein, J.P. Morgan
(11/21/12)
more >
"In Q3/12, JNJ had its best sales performance since Q1/07."
—
Michael Weinstein, J.P. Morgan
(10/16/12)
more >
"QDEL is a name that small cap investors should own."
—
Michael Weinstein, William Blair
(9/18/12)
more >
"The U.S. adoption of EW's Sapien is occurring at a pace notably ahead of expectations."
—
Michael Weinstein, J.P. Morgan
(7/20/12)
more >
"A favorable outcome is ultimately likely for FDA approval of EW's Sapien expansion."
—
Michael Weinstein, J.P. Morgan
(6/11/12)
more >
"EW has a lot of growth in front of it."
—
Michael Weinstein, J.P. Morgan
(4/13/12)
more >
"EW could post significant upside from its SAPIEN U.S. launch."
—
Michael Weinstein, J.P. Morgan
(3/26/12)
more >
